Image

Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria

Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria

Recruiting
18-75 years
All
Phase 2/3
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The purpose of this study is to compare the efficacy and safety of ICP-332 in moderate to severe chronic spontaneous urticaria subjects inadequately controlled by second generation H1-antihistamines

Eligibility

Inclusion Criteria:

  • 1\. Men and women aged 18 to 75 years.
  • 2\. Diagnosis of CSU inadequately controlled by second generation H1-antihistamines.
  • 3\. CSU duration for ≥ 6 months prior to randomization.
  • 4\. Before initiating any screening or study-specific procedures, the subject must voluntarily sign the informed consent form.

Exclusion Criteria:

  • 1\. Having the other medical conditions related to CSU or other skin diseases/conditions.
  • 2\. Potential medical conditions or issues.
  • 3\. Pregnant female subjects or lactating female subjects.
  • 4\. The investigator determines that the subject is unsuitable for participating in this study for any reason.

Study details
    Chronic Spontaneous Urticaria (CSU)

NCT07378527

Beijing InnoCare Pharma Tech Co., Ltd.

13 May 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.